Skip to main content
. 2018 Jun 7;2(3):481–489. doi: 10.1002/rth2.12119

Table 1.

Patient demographics

Characteristic Overall (N = 27 778) High riska (N = 9374) Non‐high risk (N = 18 404)
Demographic
Age in yearsa; median (IQR) 66 (50‐79) 73 (60‐81) 61 (44‐76)
Female; n (%) 12 698 (46%) 4207 (45%) 8491 (46%)
Comorbidities; n (%)
Cancerb 3476 (13%) 2974 (32%) 502 (3%)
Obesityb 7098 (26%) 4807 (51%) 2291 (12%)
Hypercoagulabilityb 1881 (7%) 1759 (19%) 122 (1%)
Prior VTEb 4766 (17%) 4641 (50%) 125 (1%)
Hormone replacement therapyb 864 (3%) 584 (6%) 280 (2%)
Congestive heart failure 8215 (30%) 4044 (43%) 4171 (23%)
Diabetes 6629 (24%) 2680 (29%) 3949 (21%)
Current tobacco use 6984 (25%) 1860 (20%) 5124 (28%)
Hospital detail; n (%)
Bed resta 10 042 (36%) 6774 (72%) 3268 (18%)
Surgery (in the past month)b 3621 (13%) 3071 (33%) 550 (3%)
Central venous catheter 2995 (11%) 1773 (19%) 1222 (7%)
Infection 7076 (25%) 2710 (29%) 4366 (24%)
PICC line 1903 (7%) 856 (9%) 1047 (6%)
Sepsis 4566 (16%) 1760 (19%) 2806 (15%)
ICU admission 11 529 (42%) 3910 (42%) 7619 (41%)
Length of stay (days); median (IQR) 2.9 (1.7‐4.8) 3.5 (2.1‐5.7) 2.7 (1.6‐4.1)

ICU, intensive care unit; PICC, peripherally inserted central catheter; VTE, venous thromboembolism.

a

Patients at high risk for at least 50% of their hospital stay were classified as high risk overall.

b

Component of the risk stratification score.